Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147.
Lantibiotics are antimicrobial peptides which contain a high percentage of post-translationally modified residues. While most attention has been paid to the role of these critical structural features, evidence continues to emerge that charged amino acids also play a key role in these peptides. Here 16 'charge' mutants of the two-peptide lantibiotic lacticin 3147 [composed of Ltnα (2+, 2-) and Ltnβ (2+)] were constructed which, when supplemented with previously generated peptides, results in a total bank of 23 derivatives altered in one or more charged residues. When examined individually, in combination with a wild-type partner or, in some instances, in combination with one another, these mutants reveal the importance of charge at specific locations within Ltnα and Ltnβ, confirm the critical role of the negatively charged glutamate residue in Ltnα and facilitate an investigation of the contribution of positively charged residues to the cationic Ltnβ. From these investigations it is also apparent that the relative importance of the overall charge of lacticin 3147 varies depending on the target bacteria and is most evident when strains with more negatively charged cell envelopes are targeted. These studies also result in, for the first time, the creation of a derivative of a lacticin 3147 peptide (LtnβR27A) which displays enhanced specific activity.
Department of Microbiology and Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland.
Lucy H
LH
Deegan
Srinivas
S
Suda
Elaine M
EM
Lawton
Lorraine A
LA
Draper
Floor
F
Hugenholtz
Andreas
A
Peschel
Colin
C
Hill
Paul D
PD
Cotter
R Paul
RP
Ross
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001430:Bacteriocins / Q000235:genetics* / Q000494:pharmacology*; D013294:Lactococcus lactis / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D011487:Protein Conformation; D013211:Staphylococcus aureus / Q000187:drug effects; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D001430:Bacteriocins; C082508:lacticin 481
Science. 2006 Sep 15;313(5793):1636-7
16973881
Annu Rev Microbiol. 2007;61:477-501
17506681
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17243-8
17085596
J Bacteriol. 2006 Aug;188(16):5797-805
16885447
Mol Microbiol. 2006 Dec;62(5):1325-39
17042784
Appl Environ Microbiol. 1996 Feb;62(2):612-9
8593062
Curr Pharm Des. 2002;8(9):815-33
11945173
Mini Rev Med Chem. 2007 Dec;7(12):1236-47
18220976
Biochemistry. 1997 Jun 10;36(23):6968-76
9188693
J Biol Chem. 1999 Mar 26;274(13):8405-10
10085071
Appl Environ Microbiol. 1998 Dec;64(12):4803-8
9835565
Nat Rev Microbiol. 2005 Oct;3(10):777-88
16205711
Antimicrob Agents Chemother. 2005 Jul;49(7):2606-11
15980326
Chem Rev. 2005 Feb;105(2):633-84
15700960
Science. 2004 Jan 30;303(5658):679-81
14752162
Microbiology (Reading). 2000 Sep;146 ( Pt 9):2147-2154
10974102
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18584-9
16339304
Appl Environ Microbiol. 2003 Jul;69(7):3777-83
12839744
J Mol Microbiol Biotechnol. 2007;13(4):226-34
17827973
Eur J Biochem. 1997 Jul 1;247(1):114-20
9249016
Appl Environ Microbiol. 1993 Jul;59(7):2014-21
8357242
Biochemistry. 2008 Jul 15;47(28):7342-51
18570437
Antimicrob Agents Chemother. 2006 May;50(5):1753-61
16641446
Science. 1999 Dec 17;286(5448):2361-4
10600751
FEMS Microbiol Lett. 2007 Feb;267(1):64-71
17233677
Chem Biol. 2008 Oct 20;15(10):1035-45
18940665
J Exp Med. 2001 May 7;193(9):1067-76
11342591
Mol Microbiol. 2002 Jan;43(1):1-14
11849532
Appl Environ Microbiol. 2007 Sep;73(18):5809-16
17660303
PLoS Pathog. 2007 Jul 27;3(7):e102
17676995
FEBS Lett. 2001 Jul 20;501(2-3):146-50
11470274
Appl Environ Microbiol. 1995 Aug;61(8):2873-8
7487019
Chem Biol. 2008 Jan;15(1):22-31
18215770
Appl Microbiol Biotechnol. 2004 Jun;64(6):806-15
15048591
Biochemistry. 2008 Mar 11;47(10):3308-14
18266322
Biosci Biotechnol Biochem. 2000 Nov;64(11):2420-8
11193411
J Biol Chem. 1992 Dec 5;267(34):24340-6
1447185
Biochemistry. 2004 Mar 23;43(11):3049-56
15023056
FEMS Microbiol Lett. 2005 Nov 15;252(2):235-41
16194596
Lett Appl Microbiol. 1999 May;28(5):355-8
10347889
J Bacteriol. 2005 Oct;187(19):6719-25
16166534
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19896-901
17179039
J Leukoc Biol. 2005 Apr;77(4):466-75
15582982
Appl Environ Microbiol. 2003 Jan;69(1):702-6
12514066
J Biol Chem. 2001 Jan 19;276(3):1772-9
11038353
Mol Microbiol. 2003 Sep;49(6):1615-25
12950925
Mol Microbiol. 2006 Nov;62(3):735-47
17076667
Antimicrob Agents Chemother. 2008 Feb;52(2):612-8
17999970
BMC Microbiol. 2007 Apr 02;7:24
17407564
Appl Environ Microbiol. 2000 Jun;66(6):2565-71
10831439
Mol Microbiol. 1998 Oct;30(2):317-27
9791177
Mol Microbiol. 2008 Jul;69(1):218-30
18485077
J Bacteriol. 1995 Dec;177(24):7011-8
8522504
Curr Opin Chem Biol. 2004 Oct;8(5):498-507
15450492
Microbiology (Reading). 2001 Mar;147(Pt 3):643-651
11238971
Curr Protein Pept Sci. 2005 Feb;6(1):61-75
15638769
Antonie Van Leeuwenhoek. 1996 Feb;69(2):161-69
8775976
Chem Biol. 2006 Oct;13(10):1109-17
17052615
Antimicrob Agents Chemother. 2005 Feb;49(2):541-8
15673730
Mol Microbiol. 2006 Jul;61(2):285-96
16771847